TY  - GEN
AU  - Cobos-Palacios, Lidia
AU  - Sanz-Cánovas, Jaime
AU  - Muñoz-Ubeda, Mónica
AU  - Lopez-Carmona, María Dolores
AU  - Perez-Belmonte, Luis Miguel
AU  - Lopez-Sampalo, Almudena
AU  - Gomez-Huelgas, Ricardo
AU  - Bernal-Lopez, Maria Rosa
PY  - 2021
DO  - 10.3389/fcvm.2021.779044
UR  - http://hdl.handle.net/20.500.12105/18510
AB  - Atherosclerotic cardiovascular diseases (ASCVD) are the leading cause of death worldwide. High levels of total cholesterol-and of low-density lipoprotein cholesterol in particular-are one of the main risk factors associated with ASCVD. Statins are...
LA  - eng
PB  - Frontiers Media
KW  - Statins
KW  - Elderly
KW  - Cardiovascular prevention
KW  - Frailty
KW  - Review
KW  - Secondary prevention
KW  - Atherosclerotic cardiovascular diseases
KW  - Hypercholesterolemia
KW  - Polypharmacy
KW  - Primary prevention
KW  - Cholesterol
KW  - Morbidity
KW  - Inhibidores de hidroximetilglutaril-CoA reductasas
KW  - Anciano
KW  - Enfermedades cardiovasculares
KW  - Fragilidad
KW  - Revisión
KW  - Prevención secundaria
KW  - Hipercolesterolemia
KW  - Polifarmacia
KW  - Prevención primaria
KW  - Colesterol
KW  - Morbilidad
KW  - Humans
KW  - Middle Aged
KW  - Aged
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Secondary Prevention
KW  - Cardiovascular Diseases
KW  - Hypercholesterolemia
KW  - Cause of Death
KW  - Accidental Falls
KW  - Polypharmacy
KW  - Primary Prevention
KW  - Cholesterol
KW  - Risk Factors
KW  - Muscular Diseases
KW  - Lipoproteins, LDL
KW  - Physicians
KW  - Morbidity
TI  - Statin Therapy in Very Old Patients: Lights and Shadows
TY  - review article
ER  -